Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 27, 2008
Ocular trauma resulting from paintball injuryPatricia J Pahk, Ron A AdelmanArchives of Ophthalmology (Chicago, Ill. : 1960)|July 16, 2003
The ability of periorbitally applied antiglare products to improve contrast sensitivity in conditions of sunlight exposureBrian M DeBroff, Patricia J PahkClinical Ophthalmology (Auckland, N.Z.)|October 7, 2014
Cataract formation following vitreoretinal proceduresHao Feng, Ron A AdelmanGraefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 11, 2008
Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?Fang Lu, Ron A AdelmanSeminars in Ophthalmology|July 13, 2012
Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum: five-year follow-upNazlee Zebardast, Ron A AdelmanAmerican Journal of Ophthalmology|July 3, 2009
A study of interactions between pharmaceutical representatives and ophthalmology traineesYue Wang, Ron A AdelmanJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 18, 2012
Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988-2008) review in northeast United StatesXuejing Chen, Ron A AdelmanJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 4, 2011
The treatment of recurrent central serous chorioretinopathy with intravitreal bevacizumabShelly T Lee, Ron A AdelmanJournal of Vitreoretinal Diseases|November 14, 2024
Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021Eric S Li, Ron A AdelmanClinical Ophthalmology (Auckland, N.Z.)|October 5, 2013
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathyShaheen P Karim, Ron A AdelmanPageof 11